findmyKOL
Clinical trialNCT01349660CompletedPhase 1/PHASE2Interventional

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

SponsorSCRI Development Innovations, LLCEnrollment88Glioblastoma Multiforme
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Yale School of Medicine

    New Haven, Connecticut, United States

  • Florida Cancer Specialists

    Fort Myers, Florida, United States

  • Florida Hospital Cancer Institute

    Orlando, Florida, United States

  • Florida Cancer Specialists

    St. Petersburg, Florida, United States

  • Center for Cancer and Blood Disorders

    Bethesda, Maryland, United States

  • Grand Rapids Oncology Program

    Grand Rapids, Michigan, United States

  • Nebraska Methodist Hospital

    Omaha, Nebraska, United States

  • Tennessee Oncology

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2011
Primary completion
31 Dec 2016
Completion
29 Dec 2018
Last update posted
17 Jun 2020
Registered enrollment
88
Registry id
NCT01349660

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.